Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine

Purpose: Adenosine plays an important role in the pathogenesis of homocysteine-associated vascular complications. Methods: This study examined the effects of dipyridamole, an inhibitor for nucleoside transport, on impaired angiogenic processes caused by homocysteine and adenosine in human cardiovasc...

Full description

Saved in:
Bibliographic Details
Main Authors: Antony Kam (Author), Valentina Razmovski-Naumovski (Author), Xian Zhou (Author), John Troung (Author), Kelvin Chan (Author)
Format: Book
Published: Frontiers Media S.A., 2015-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1f27ac7d14d14b6f8cbf94b45e2c5ef6
042 |a dc 
100 1 0 |a Antony Kam  |e author 
700 1 0 |a Valentina Razmovski-Naumovski  |e author 
700 1 0 |a Xian Zhou  |e author 
700 1 0 |a John Troung  |e author 
700 1 0 |a Kelvin Chan  |e author 
245 0 0 |a Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine 
260 |b Frontiers Media S.A.,   |c 2015-12-01T00:00:00Z. 
500 |a 10.18433/J3TG88 
500 |a 1482-1826 
520 |a Purpose: Adenosine plays an important role in the pathogenesis of homocysteine-associated vascular complications. Methods: This study examined the effects of dipyridamole, an inhibitor for nucleoside transport, on impaired angiogenic processes caused by homocysteine and adenosine in human cardiovascular endothelial cell line (EAhy926). Results: The results showed that dipyridamole restored the extracellular adenosine and intracellular S-adenosylhomocysteine concentrations disrupted by the combination of homocysteine and adenosine. Dipyridamole also ameliorated the impaired proliferation, migration and formation of capillary-like tubes of EAhy926 cells caused by the combination of homocysteine and adenosine. Mechanism analysis revealed that dipyridamole induced the phosphorylation of mitogen-activated protein kinase kinase (MEK) and extracellular signal-regulated kinases (ERK) and its effect on cell growth was attenuated by the MEK inhibitor, U0126. Conclusion: Dipyridamole protected against impaired angiogenesis caused by homocysteine and adenosine, at least in part, by activating the MEK/ERK signalling pathway, and this could be associated with its effects in suppressing intracellular S-adenosylhomocysteine accumulation. Novelty of the Work: This is the first paper showing that nucleoside transport inhibition by dipyridamole reduced impaired angiogenic process caused by homocysteine and adenosine. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy & Pharmaceutical Sciences, Vol 18, Iss 5 (2015) 
787 0 |n https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/25377 
787 0 |n https://doaj.org/toc/1482-1826 
856 4 1 |u https://doaj.org/article/1f27ac7d14d14b6f8cbf94b45e2c5ef6  |z Connect to this object online.